Genentech Announces Interim Results from Phase III HAVEN 2 Study
On April 16, 2017 GenentechÂ announced interim resultsÂ from the Phase III HAVEN 2 study evaluating emicizumab prophylaxis in childrenÂ less than 12 years of age with hemophilia A and inhibitors to factor VIII. According to this Genentech’s press releases, “interim analysis after a median of 12 weeks of treatment, emicizumab prophylaxisÂ showed a clinically meaningful reduction in the […]
Pharmaceutical Companies Recognize World Hemophilia Day
Today, on World Hemophilia Day, many pharmaceutical companies joined in the celebration by recognizing and supporting the hemophilia community. Linked below are statements from a wide group of companies on today’s celebration of World Hemophilia Day:Grifols Press ReleaseBioverativ Press ReleaseNovo Nordisk on supporting women with bleeding disordersShire Press ReleaseCSL Behring Press Release
Bioverativ Strengthens Commitment To Women With Bleeding Disorders
BioverativÂ joins the global hemophilia community in recognizing World Hemophilia Day and supporting the millions of women and girls impacted by bleeding disorders through this year’s theme, “Hear Their Voices.”Excerpted from the press release: “Bioverativ shares the World Federation of Hemophilia’s commitment to understanding the needs of all members of the bleeding disorders community, including women, […]
Novo Nordisk Recognizes World Hemophilia Day
Drug manufacturer, Novo Nordisk recognized World Hemophilia Day 2017 by celebrating the theme of the year; Hear Their Voices, by showing support for women with bleeding disorders. To learn more, read Novo Nordisk’s press release in it’s entirety.Â here.
Shire Recognizes World Hemophilia Day
Clotting factor manufacturer, Shire, is celebrating World Hemophilia Day in part by hosting an awareness rally in Chicago, Illinois. The rally is aimed mainly to educate the public on the dramatic estimate of a hemophilia bleeding episode occurring worldwide every 3-15 seconds. See more on their website.Read a full statement fromÂ Shire recognizing World Hemophilia Day.
Grifols Donates 140 Million Units of Factor on World Hemophilia Day
As part ofÂ World Hemophilia Day celebrations, Grifols has announced a large donation of clotting factor to the World Federation of Hemophilia (WFH) Humanitarian Aid Program.Â This announcement is a continuation of the company’s three-year commitment from 2014, bringing the total humanitarian aid commitment to more than 200M IU of Factor VIII over eight yearsRead the full […]